|
ACS Nano
|
20 |
|
|
|
Acta Biomaterialia
|
25 |
|
|
|
Advanced Functional Materials
|
8 |
|
|
|
Advanced Materials
|
1 |
|
|
|
American Journal of Clinical Nutrition
|
9 |
|
|
|
American Journal of Epidemiology
|
10 |
|
|
|
American Journal of Obstetrics and Gynecology
|
1 |
|
|
|
American Journal of Pathology
|
5 |
|
|
|
American Journal of Respiratory and Critical Care Medicine
|
72 |
|
Occupational Exposure to Dust and Fumes Increases Risk for Future Adverse Clinical Outcomes
|
|
The frequent exacerbator phenotype in bronchiectasis revisited: Data from EMBARC registry
|
|
Identification of Pulmonary Arterial Hypertension Patients with Venous or Capillary Involvement
|
|
Defining disease stability in COPD: Evidence from Phase 3 clinical trials
|
|
Mepolizumab Efficacy in COPD: Insights from Longitudinal Patterns of Blood Eosinophil Counts and Their Variability Across Three Clinical Trials
|
|
Early neutrophil and persistent eosinophil-associated gene signature in childhood asthma
|
|
Meaningful Thresholds for Change in Quantitative CT–Derived Fibrosis Extent in Idiopathic Pulmonary Fibrosis
|
|
Astegolimab for COPD With Frequent Exacerbations: Pooled Analysis of the ALIENTO and ARNASA Trials
|
|
Tezepelumab in Real-World U.S. Patients with Severe Asthma Across Phenotypes and Underrepresented Populations: The Phase 4 PASSAGE Study
|
|
Single-cell Sequencing Unveils A Profibrotic Macrophage and Infiltrating Monocyte Niche in the Bronchoalveolar Lavage of Patients with Chronic Obstructive Pulmonary Disease
|
|
Aroxybutynin and atomoxetine (AD109) for obstructive sleep apnea: a randomized phase 3 trial (SynAIRgy)
|
|
Dupilumab in COPD: A Pooled Analysis of Emergency Department Visits, Hospital Admissions, and Systemic Corticosteroid Use
|
|
From mild-to-moderate to severe asthma: Risk factors and patient profiles from the NORDSTAR cohort
|
|
Post-Tuberculosis Lung Disease in Treated Extra-Pulmonary Tuberculosis
|
|
Effectiveness of automatically-adjusted vs manually-adjusted noninvasive ventilation in obesity hypoventilation syndrome: a randomized clinical trial
|
|
Nerandomilast in idiopathic pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-IPF trial
|
|
Sub-phenotypes of pneumonia defined by pulmonary histopathological features
|
|
Idiopathic Pulmonary Fibrosis Risk Loci in East Asian Populations Mirror those of European Populations
|
|
Deupirfenidone Compared with Pirfenidone and Placebo in Idiopathic Pulmonary Fibrosis (ELEVATE-IPF): a Phase 2b Randomized Placebo-Controlled Trial
|
|
Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertension
|
|
Molecular endotypes predict differential response to immunosuppressant therapy in non–idiopathic pulmonary fibrosis interstitial lung disease
|
|
Mast Cells and Endothelial Cells Mediate Interleukin-33 and ST2 Responses in Distal COPD Lungs
|
|
Pamufetinib (TAS-115) for Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A double-blind, multicenter, phase 2b Clinical Trial
|
|
Mosaic Loss of Y chromosome associates with lung function, emphysema and epigenetic aging
|
|
Discriminative Performance and Clinical utility of COPD Exacerbation Categories for Predicting Future Exacerbations
|
|
CES1 Deficiency is Associated With Metabolic Reprograming and Endothelial Dysfunction in Pulmonary Arterial Hypertension
|
|
Pulmonary Rehabilitation is Associated with Increased 1-Year Survival in Stable COPD
|
|
Standalone Prognostication of Idiopathic Pulmonary Fibrosis Using Attention-Based Deep Learning
|
|
Clinical and transcriptomic risk factors for post-tuberculosis lung disease in a cohort of Kenyan adults
|
|
The Long-term Pneumonia Mortality Index. An International Multicenter Derivation and Validation Study for Patients with Community-Acquired Pneumonia
|
|
Identification of a conserved sequence of disease progression in Idiopathic Pulmonary Fibrosis
|
|
Motivational Interviewing and Air Cleaners for Smokers with COPD (MOVE): A Randomized, Double-Blind, Placebo-Controlled Trial
|
|
Extracellular Vesicle Cargo from Lipofibroblasts Mitigates COPD by Alveolar Type II Cell Restoration
|
|
Mucus plugs in chronic obstructive pulmonary disease are heterogeneous in size and shape and occur in relatively large airways
|
|
International validation of electronic nose technology as diagnostic tool for fibrotic interstitial lung diseases
|
|
Lower airway immunophenotyping in severe preschool wheeze reveals distinct clusters described by heterogeneity in neutrophil phenotypes
|
|
Effect of Dupilumab on Mucus Burden in Patients with Moderate-to-Severe Asthma: The VESTIGE Trial.
|
|
Lung Involvement of Myeloid-Lymphoid Neoplasia with Eosinophilia
|
|
Mucus Plugs-associated Gene Expression Identifies Pathophysiology Shared with Chronic Bronchitis.
|
|
Phenotyping Asthma and/or COPD Using 129Xe MRI and Comprehensive Physiologic Testing.
|
|
Patient Factors and Clinical Efficacy of Early Identification and Treatment of COPD and Asthma.
|
|
p300-Dependent Modulation in Regulatory T Cells Plays a Crucial Role in Allergic Asthma.
|
|
Outcomes of a Typical Fibrotic Hypersensitivity Pneumonitis Pattern on Chest Computed Tomography
|
|
Airway Epithelial Heterogeneity and Mucus Plugging in Asthmatic Bronchioles.
|
|
Upper Airway Microbiome, Mucociliary Function, and Clinical Outcomes in Bronchiectasis: Data from the EMBARC-BRIDGE Study.
|
|
Cardiopulmonary Hemodynamic Determinants of Long-Term Survival in Sickle Cell Disease: Insights from the ETENDARD Study.
|
|
Randomized Sham Controlled Trial of Targeted Lung Denervation in Patients with COPD (AIRFLOW-3).
|
|
Mucus Plugs Correlate with Small Airway Remodelling in Asthma: A Case-Control Study.
|
|
Associations of High Attenuation Area-related Proteomic Biomarkers with Fibrotic or Subpleural Interstitial Lung Abnormalities.
|
|
One-Year Change in Quantitative Computed Tomography Is Associated with Meaningful Outcomes in Fibrotic Lung Disease.
|
|
Ionocyte CFTR Coordinates Chloride Absorption and Secretion to Balance Airway Fluid.
|
|
Active Antigen-Specific Adaptive Immune Responses Are Shared among Patients with Progressive Fibrotic Interstitial Lung Disease.
|
|
Distinct Morphological Types of Small Airway Obstructions in Smokers with Emphysema and End-Stage COPD.
|
|
Impact of Sleep Apnea on Perivascular Diffusivity and Cognition: A 4-Year Prospective Cohort Study.
|
|
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance and Abnormal Glucose Metabolism: A Phase 3b, Open-Label Clinical Trial.
|
|
Inflammation and Obesity Correlate in Pulmonary Hypertension but Associate with Diverging Outcomes.
|
|
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in ILD-PH: A PVRI GoDeep Meta-Registry Analysis.
|
|
A Large-Scale Single-Cell Atlas Reveals the Peripheral Immune Panorama of Bacterial Pneumonia.
|
|
Non-Coding DNA Variants Increase the Genetic Diagnostic Yield in Primary Ciliary Dyskinesia.
|
|
Clustering Patients with Pulmonary Hypertension Using the Plasma Proteome
|
|
Proteomic Biomarkers of Survival in Non–Idiopathic Pulmonary Fibrosis Interstitial Lung Disease
|
|
Right Ventricular Strain and Outflow Tract Velocity Time Integral Are Associated with Mortality in Critically Ill Patients with Pulmonary Embolism
|
|
Visual and Quantitative Interstitial Lung Abnormality Progression in COPDGene.
|
|
A Long-Term Physical Activity Coaching Program for Patients with COPD: A Randomized Controlled Trial.
|
|
A Quantitative Imaging Measure of Progressive Pulmonary Fibrosis.
|
|
Molecular Phenotyping of Sepsis and Differential Response to Fluid Resuscitation.
|
|
Endotypes of Pseudomonas aeruginosa Infection in Bronchiectasis Are Associated with Inhaled Antibiotic Response: Results from Two Randomized, Double-Blind, Placebo-controlled Phase III Trials (ORBIT 3 and ORBIT 4).
|
|
The Plasma Proteome in Community-acquired Pneumonia: Pathophysiology, Outcome and 10-Year Risk.
|
|
Lipid Ratios for Diagnosis and Prognosis of Pulmonary Hypertension
|
|
Deep Learning Estimation of Small Airway Disease from Inspiratory Chest Computed Tomography: Clinical Validation, Repeatability, and Associations with Adverse Clinical Outcomes in Chronic Obstructive Pulmonary Disease
|
|
Associations of Prepandemic Lung Function and Structure with COVID-19 Outcomes: The C4R Study
|
|
Dual αvβ6 and αvβ1 Inhibition over 12 Weeks Reduces Active Type I Collagen Deposition in Individuals with Idiopathic Pulmonary Fibrosis: A Phase 2, Double-Blind, Placebo-controlled Clinical Trial
|
|
|
Analytical Chemistry
|
18 |
|
|
|
Anesthesiology
|
8 |
|
|
|
Angewandte Chemie International Edition
|
2 |
|
|
|
Annals of Emergency Medicine
|
5 |
|
|
|
Annals of Internal Medicine
|
7 |
|
|
|
Annals of Neurology
|
4 |
|
|
|
Annals of Surgery
|
5 |
|
|
|
Annals of the Rheumatic Diseases
|
7 |
|
|
|
Applied Physics Letters
|
2 |
|
|
|
Archives of Physical Medicine and Rehabilitation
|
7 |
|
|
|
Arthritis & Rheumatology
|
18 |
|
|
|
Blood
|
28 |
|
|
|
Brain
|
2 |
|
|
|
British Journal of Surgery
|
10 |
|
|
|
Cancer Cell
|
2 |
|
|
|
Cell
|
3 |
|
|
|
Cell Host & Microbe
|
3 |
|
|
|
Cell Metabolism
|
3 |
|
|
|
Cell Stem Cell
|
5 |
|
|
|
Chemical Communications
|
1 |
|
|
|
Chemical Science
|
3 |
|
|
|
Chest
|
98 |
|
|
|
Circulation
|
105 |
|
Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry.
|
|
Vacuolar H+-ATPase Preserves Cardiolipin Homeostasis Through the Lysosomal-Mitochondrial Axis to Restrain Cardiac Aging.
|
|
Sirolimus-Eluting Balloon With Provisional Stenting Versus Systematic Drug-Eluting Stent Implantation to Treat De Novo Coronary Lesions: A Randomized, Open-Label, Noninferiority Trial
|
|
Endothelial SHMT2 Drives Pulmonary Vascular Remodeling Through Noncanonical Pathway in Pulmonary Hypertension.
|
|
Heart Rate and Cardiovascular Outcomes in Post-Myocardial Infarction Patients Treated by β-Blockers: A Secondary Analysis of the ABYSS Trial.
|
|
Alternative Splicing of TPM1 Mediated by SRPK3 Drives Cardiac Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction
|
|
Incremental Prognostic Value of Subendocardial Myocardial Flow Reserve in Patients With Normal Perfusion
|
|
A Genome-First Study of Familial Hypercholesterolemia Comparing African and European Ancestry Individuals
|
|
Integrative Molecular Analyses of Inflammatory and Autoimmune Signals in Cardiac Sarcoidosis
|
|
Pulsed Field Ablation Versus Sham to Treat Atrial Fibrillation: The PFA-SHAM Randomized Clinical Trial
|
|
Hypoxia Upregulation of BACH1 Aggravates Pulmonary Hypertension Through TGFBR2/SMAD Pathways
|
|
Lipoprotein(a) Levels, Risk of Cardiovascular Events, and Benefit of Evolocumab: Findings From the VESALIUS-CV Trial
|
|
Sam68 Exacerbates Pathologic Cardiac Hypertrophy by Suppressing Cardiomyocyte Glucose Oxidation
|
|
Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior Myocardial Infarction: Results From the VESALIUS-CV Trial
|
|
Laroprovstat, the First Oral Small-Molecule PCSK9 Inhibitor for the Treatment of Hypercholesterolemia: Results From a Randomized, Single-Blind, Placebo-Controlled Phase 1 Trial in Treatment-Naïve Patients
|
|
Determining the Physiological Threshold for Angina (ORBITA-FIRE): A Double-Blind, Randomized, Placebo-Controlled Study.
|
|
GPRASP1 Safeguards Endothelial Aspartate Metabolism to Prevent Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction.
|
|
JNK2 Is a Stress Integrator Driving Atrial Fibrillation Pathogenesis in Aging via Gut-Heart Crosstalk.
|
|
The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.
|
|
Phone-Based Intervention Under Nurse Guidance for Control of Hypertension After Stroke: A Randomized Multicenter Phase 3 Trial in Ghana.
|
|
Mir147 Limits the Contribution of Non-Foamy Macrophages to Atherosclerosis.
|
|
Cardiovascular-Kidney-Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study.
|
|
The Fontan Outcomes Network: Findings After 2 Years and 1121 Participants.
|
|
Memantine for Premature Atrial Contractions: A Phase 2 Randomized Clinical Trial.
|
|
CRLF1 Secreted by Cardiac Fibroblasts Promotes Human Hypertrophic Cardiomyopathy
|
|
TRIM28 Is an E3 Ligase of IRP2 Suppressing Ischemia/Reperfusion-Induced Myocardial Ferroptosis.
|
|
A Critical Contribution of Cardiac Myofibroblasts in Right Ventricular Failure and the Role of UCP2 SNPs in the Predisposition to RV Decompensation in Pulmonary Arterial Hypertension.
|
|
Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic Cardiomyopathy.
|
|
Aortic and Iliac Calcifications as Predictors of Aortic Dissection, Aneurysm Rupture, and Peripheral Vascular Disease: A Prospective Cohort Study from the DANCAVAS Trials.
|
|
Small Extracellular Vesicle External Surface Adiponectin-Mediated Adipocytes/Cardiomyocytes Communication in Diabetic Ischemic Heart Failure.
|
|
PAM-VT 2 Study: Long-Term Scar Evolution and Ablation Lesion Assessment by Late Gadolinium Enhancement Cardiac Magnetic Resonance After Ventricular Tachycardia Ablation.
|
|
Risk of Heart Failure Hospitalization for GLP-1 Receptor Agonists Versus DPP-4 Inhibitors or SGLT-2 Inhibitors in Patients With Type 2 Diabetes: A Target Trial Emulation.
|
|
CCR8 Expression on Regulatory T Cells Reveals Trajectories of Tissue Adaptation and Protects Against Myocardial Infarction-Induced Tissue Damage.
|
|
Elevated Pulmonary Artery Wedge Pressure in Group 1 Pulmonary Hypertension.
|
|
Prospective Associations of Obesity and Obesity Severity With 9 Cardiovascular Outcomes: The Cross-Cohort Collaboration.
|
|
Natural History of Patients With Histologically Proven Acute Eosinophilic Myocarditis.
|
|
Defining an Optimal Result of Transcatheter Tricuspid Valve Intervention: Results From the Tri-QOL Study
|
|
Systemic Embolic Events in Atrial Fibrillation: An Individual Patient Data Meta-analysis of 71 683 Participants Randomized to NOAC Versus Warfarin.
|
|
Association of Pre-Fontan Hemodynamics With Long-Term Outcomes After Fontan Palliation: A Study From the Pediatric Cardiac Care Consortium
|
|
CXCR6+ T Cells Drive Immune Checkpoint Inhibitor Myocarditis.
|
|
Prognostic Implications of Evolving Universal Definitions of Periprocedural Myocardial Infarction in Patients With Acute Coronary Syndrome.
|
|
Inhibition of Annexin A2 Facilitates PHB2-Mediated Mitophagy in Cardiomyocytes to Alleviate Cardiac Injury and Remodeling After Infarction.
|
|
Myocardial Recovery With Mechanical Circulatory Support Is Linked to Alternative Splicing and Subcellular Localization of CAMK2D.
|
|
Engineered Regulatory T Lymphocytes Promote Infarcted Heart Repair.
|
|
Macrophage-Specific E3 Ubiquitin Ligase TRIM31 Reduces Atherosclerotic Plaque Formation by Targeting LOX-1.
|
|
IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes.
|
|
Endothelial Transcription Factor EB Protects Against Doxorubicin-Induced Endothelial Toxicity and Cardiac Dysfunction.
|
|
Bradycardia in Athletes: Prevalence, Mechanisms, and Risks.
|
|
S-Nitrosylation of Pyruvate Kinase Isoform 2 Drives Cardiac Fibrosis by Promoting Mitochondrial Fission.
|
|
Safety, Utility, and Outcomes of Procainamide Challenge for the Diagnosis and Exclusion of Brugada Syndrome.
|
|
Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes After Acute Coronary Syndrome
|
|
Leveraging a Genetic Proxy to Investigate the Effects of Lifelong Cardiac Sodium Channel Blockade.
|
|
OxLDL-Targeted Chimeric Antigen Receptor T Regulatory Cells Reduce Atherosclerotic Plaque Development.
|
|
Sacubitril-Valsartan for the Prevention of Anthracycline Cardiotoxicity in Patients With Elevated Cardiac Troponin I Concentration During Chemotherapy: A Double-Blind Randomized Placebo-Controlled Clinical Trial: The SARAH Trial.
|
|
Quantitative Identification of High-Risk Tricuspid Regurgitation by Cardiac Magnetic Resonance.
|
|
Cardiac Allograft Vasculopathy Inhibition with Alirocumab: The CAVIAR Trial.
|
|
Dapagliflozin to Reduce Early Recurrence After Catheter Ablation for Atrial Fibrillation: The DARE-AF Randomized Clinical Trial.
|
|
Incidence, Risk Factors, and Outcomes in Stressor-Associated Atrial Fibrillation: Insights from the VITAL-AF Trial
|
|
Deep Learning–Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation
|
|
Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempeDACS Randomized Clinical Trial.
|
|
Prognostic Value of Exercise Right Ventricular-Pulmonary Arterial Coupling in Primary Mitral Regurgitation.
|
|
Efficacy and Safety of Very Low Achieved LDL-Cholesterol in Patients with Prior Ischemic Stroke.
|
|
Combined Adaptive Immune Mechanisms Mediate Cardiac Injury After COVID-19 Vaccination.
|
|
Geometric Features of Ventricular Tachycardia Corridors in Patients With Ischemic Cardiomyopathy.
|
|
IRF5 siRNA Nanoimmunotherapy: Restoring Macrophage Efferocytosis in Atherosclerosis.
|
|
Nuclear eNOS Interacts With and S-Nitrosates ADAR1 to Modulate Type I Interferon Signaling and Endothelial Function.
|
|
The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled Study.
|
|
Short-Term Anticoagulation versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure: The ANDES Randomized Clinical Trial.
|
|
Heart Stress and Blood Pressure Management in Older Adults: Post Hoc Analysis of the ASPREE Trial.
|
|
Bailout Intracranial Angioplasty or Stenting After Thrombectomy for Acute Large Vessel Occlusion: 1-Year Outcomes of ANGEL-REBOOT.
|
|
ALDH2/eIF3E Interaction Modulates Protein Translation Critical for Cardiomyocyte Ferroptosis in Acute Myocardial Ischemia Injury.
|
|
Hypercontractility and Oxidative Stress Drive Creatine Kinase Dysfunction in Hypertrophic Cardiomyopathy.
|
|
Transcatheter Closure of Patent Foramen Ovale With a Novel Biodegradable Device: A Prospective, Multicenter, Randomized Controlled Clinical Trial.
|
|
High-Voltage Focal Pulsed Field Ablation to Treat Scar-Related Ventricular Tachycardia: The First-in-Human VCAS Trial.
|
|
Single-Cell Splicing Isoform Atlas of the Adult Human Heart and Heart Failure.
|
|
Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults.
|
|
Screening-Detected Atrial Fibrillation and Cardiovascular Outcomes in Working-Age Adults.
|
|
PYGM Protects Against Myocardial Infarction by Enhancing Glycogenolysis and Facilitating Autophagic Flux.
|
|
Fibroblast-Specific Loss of TGF-β Signaling Mediates Lipomatous Metaplasia in the Infarcted Heart.
|
|
Role of A2AR-D2R Dimerization and D2R-Biased Signaling in PDE10A-Mediated Cardiac Hypertrophy.
|
|
TAX1BP3 Is a SUMOylated Nucleocytoplasmic Shuttling Protein and Protects Against Vascular Neointimal Hyperplasia.
|
|
Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial.
|
|
Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIA
|
|
Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial.
|
|
Clinical Presentation and Outcomes After Surgery for Mitral Regurgitation: Real-World Insights From the MITRACURE International Registry.
|
|
Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure.
|
|
Biomarker-based ABC-AF Risk Scores for Personalized Treatment to Reduce Stroke or Death in Atrial Fibrillation - a Registry-based Multicenter Randomized Controlled Study.
|
|
Sacubitril-Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial.
|
|
Ivabradine in Patients Undergoing Noncardiac Surgery: a Randomized Controlled Trial.
|
|
Three-Year-Follow-Up of the NOTION-2 Trial: TAVR Versus SAVR to Treat Younger Low-Risk Patients with Tricuspid or Bicuspid Aortic Stenosis.
|
|
Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate Effect Variants.
|
|
Peri-interventional Anesthesia Strategies for Transcatheter Aortic Valve Implantation: A Multicenter, Randomized, Controlled, Non-inferiority Trial.
|
|
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants.
|
|
Transcatheter Aortic Valve Replacement With Balloon- Versus Self-Expandable Bioprostheses for the Treatment of Bicuspid Aortic Valve Stenosis
|
|
Human Single-Nucleus RNA Sequencing Identifies CD47 as a Therapeutic Target for Doxorubicin-Induced Cardiomyopathy.
|
|
Long-Term Outcomes of Early Surgery Versus Conventional Treatment for Asymptomatic Severe Mitral Regurgitation: A Propensity Analysis.
|
|
TBX5 and CHD4 Coordinately Activate Atrial Cardiomyocyte Genes to Maintain Cardiac Rhythm Homeostasis.
|
|
G Protein-Coupled Receptor Kinase 3 Exacerbates Diabetic Heart Injuries Through Direct Phosphorylation of Cannabinoid Receptor 2 in Humans and Mice.
|
|
Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke.
|
|
Hypertriglyceridemia as a Key Contributor to Abdominal Aortic Aneurysm Development and Rupture: Insights From Genetic and Experimental Models.
|
|
Single-Cell Multi-Omics Identifies Specialized Cytotoxic and Migratory CD8+ Effector T Cells in Acute Myocarditis.
|
|
Evaluation of Lipoprotein(a) as a Prognostic Marker of Extracoronary Atherosclerotic Vascular Disease Progression.
|
|
Junctophilin-2 Regulates Store-Operated Calcium Entry to Drive Cardiac Fibroblast Activation, Fibrotic Repair, and Angiogenesis After Myocardial Infarction.
|
|
Association of Statin Treatment and Dose With the Clinical Course of Small Abdominal Aortic Aneurysms in Men: A 5-Year Prospective Cohort Study From 2 Population-Based Screening Trials.
|
|
The Impact of Fontan Circulatory Failure on Heart Transplant Survival: A 20-Center Retrospective Cohort Study.
|
|
|
Clinical Infectious Diseases
|
8 |
|
|
|
Critical Care Medicine
|
15 |
|
|
|
Developmental Cell
|
2 |
|
|
|
Diabetes Care
|
13 |
|
|
|
Environmental Health Perspectives
|
1 |
|
|
|
Environmental Pollution
|
13 |
|
|
|
Environmental Research
|
20 |
|
|
|
Environmental Science and Technology
|
14 |
|
|
|
European Heart Journal
|
125 |
|
Cardiac remodelling and dysfunction in cancer patients receiving cardiotoxic therapies: proteomic and metabolomic profiling
|
|
Blood aldosterone concentrations and effects of mineralocorticoid receptor antagonists in heart failure
|
|
Cholesterol-lowering therapy from childhood/adolescence and long-term outcomes in familial hypercholesterolaemia: the SAFEHEART study
|
|
ACADM-mediated fatty acid β-oxidation pathway in atherosclerosis and abdominal aortic aneurysm
|
|
Predicting lifetime cardiovascular risk and benefits of preventive treatment in patients with established atherosclerotic cardiovascular disease: the SMART-REACH2 model
|
|
Safety of low lipoprotein(a) levels: the FOURIER trial
|
|
Ferroptosis promotes aortic stenosis through 5-lipoxygenase
|
|
Standard modifiable risk factors among patients undergoing percutaneous coronary intervention: prevalence and impact
|
|
GLI1 activation induced by intermittent hypoxia drives cardiac fibroblast activation via enhanced PKM2-mediated glycolysis
|
|
Tetralogy of Fallot: electrophysiology-guided surgical ablation during pulmonary valve replacement
|
|
Right aortic arch and double arch assessed by prenatal echocardiography: a population-based study
|
|
Arrhythmias, dementia risk, and neurodegeneration: a cohort study
|
|
Interleukin-6 and C-reactive protein prognostic value following acute coronary syndrome
|
|
Chimeric antigen receptor T-cell therapy and cardiovascular outcomes in US Medicare beneficiaries
|
|
Obicetrapib and lipoprotein(a) levels in patients at high cardiovascular risk: a pooled analysis of trials
|
|
Outcomes in the BETAMI-DANBLOCK trial compared with a Norwegian nationwide myocardial infarction population
|
|
Endurance exercise remodels pulmonary vein sleeve myocytes and promotes a proarrhythmic atrial substrate
|
|
Angina with non-obstructive coronary arteries and myocardial bridge: long-term outcomes of surgical unroofing
|
|
Intrapericardially injected hydrogel loaded with stromal cell secretome microparticles improves post-infarction myocardial repair in pigs
|
|
MTMR4 variants have opposite gene-specific impact on life-threatening arrhythmic risk in type 1 and 2 long QT syndrome
|
|
Molecular mechanism leading to human coronary atherosclerosis assessed by proteomic analysis and RNA sequences
|
|
Outcomes after a first acute myocardial infarction in patients with or without congenital heart disease
|
|
A nurse-coordinated intervention programme vs standard of care after an acute coronary syndrome: the ALLEPRE trial
|
|
Cancer and heart failure: prevalence, incidence, and prognosis in Scotland
|
|
PCSK9 inhibitor treatment and outcomes in patients with atherosclerotic cardiovascular disease but without prior ischaemic events: an observational study
|
|
Cardiac resynchronization therapy with or without atrioventricular node ablation in atrial fibrillation: the CAAN-AF trial
|
|
New-onset postoperative atrial fibrillation management and outcomes: the VISION Cardiac Surgery cohort
|
|
Stroke and systemic embolism following atrial fibrillation ablation: the EMBOL-AF Global Registry
|
|
Atrial fibrillation density as a biomarker for ischaemic stroke risk prediction
|
|
Sex differences in cardiovascular–kidney–metabolic syndrome: the FINE-HEART pooled analysis
|
|
Risk prediction in patients with heart failure with preserved ejection fraction: the LIFE-Preserved model
|
|
Prediction of incident heart failure in established atherosclerotic cardiovascular disease: the SMART2-HF model
|
|
Artificial intelligence–based quantification of breast arterial calcifications to predict cardiovascular morbidity and mortality
|
|
Laminopathies: natural history and risk prediction of heart failure
|
|
Aficamten in symptomatic obstructive hypertrophic cardiomyopathy: the FOREST-HCM long-term study
|
|
Nuclear AGO2 exacerbates heart failure with preserved ejection fraction through myocardial ketogenesis
|
|
SLC4A3-related short QT syndrome assessed in human induced pluripotent stem cell-derived cardiomyocytes: mechanisms of ventricular arrhythmia and sudden cardiac death
|
|
Carotid plaque macrophage burden and inflammatory lipid-associated macrophage markers predict secondary major adverse cardiovascular events after endarterectomy
|
|
Switching from warfarin to direct oral anticoagulants in frail elderly Asian patients with atrial fibrillation: a Korean nationwide study
|
|
Pelacarsen and lipoprotein(a) apheresis in secondary prevention: the Lp(a)FRONTIERS APHERESIS trial
|
|
Aspirin use, lipoprotein(a), and calcific aortic valve disease: the Multi-ethnic Study of Atherosclerosis
|
|
Arrhythmias in congenitally corrected transposition of the great arteries: an international study
|
|
Macrophage SBK2 suppresses inflammation and atherosclerosis by NLRP3 phosphorylation
|
|
Spatial transcriptomics reveals a key role of fibroblast-like vascular smooth muscle cells in human atherosclerotic cell crosstalk and stability
|
|
Soluble ST2 drives fulminant myocarditis progression via the IGF2R–YY1 mitochondrial axis
|
|
Macrophage-specific circular RNA circHIPK2, inflammation, and fibrosis after myocardial infarction
|
|
Computed tomography-guided vs conventional catheter ablation for ventricular tachycardia: the InEurHeart trial
|
|
Heart failure in the Portuguese population aged ≥50 years: prevalence and phenotypes in the PORTHOS study
|
|
Subvalvular aortic stenosis in adults: clinical course and long-term outcomes
|
|
Frozen elephant trunk for acute type A aortic dissection: long-term outcomes over two decades
|
|
Heart failure with preserved ejection fraction in adults with congenital heart disease
|
|
Peri-operative myocardial infarction/injury after non-cardiac surgery: association between cardiologist evaluation and outcomes
|
|
Peripheral autonomic dysregulation in response to standing: a new form associated with cardiovascular disease, mobility reduction, and cognitive alterations
|
|
Risk-weighted apoB: a novel summary metric outperforming traditional lipid biomarkers in predicting coronary heart disease
|
|
Foundation models for electrocardiogram interpretation: clinical implications
|
|
Pulsed field vs radiofrequency ablation for paroxysmal atrial fibrillation: the BEAT PAROX-AF trial
|
|
Anthracycline cardiotoxicity: role of metabolic vulnerability induced by cardiac pressure overload
|
|
Left bundle branch vs biventricular pacing: mechanistic insights from a canine model
|
|
Congenital heart defects: familial recurrence patterns in Sweden
|
|
Complete revascularization timing in ST-segment elevation myocardial infarction and multivessel disease with heart failure: the OPTION–STEMI trial
|
|
Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score
|
|
Adults with Fontan circulation: prognostic value of exercise pulmonary vascular resistance index
|
|
The junctional protein associated with coronary artery disease predicts adverse cardiovascular events in patients with acute coronary syndromes at high residual risk
|
|
Physiology vs angiography-guided percutaneous coronary intervention in transcatheter aortic valve implantation: the FAITAVI trial
|
|
Mitral transcatheter edge-to-edge repair and outcomes according to baseline health status: the RESHAPE-HF2 trial
|
|
Catecholaminergic polymorphic ventricular tachycardia mediated by ryanodine receptor 2: a validated risk stratification
|
|
Atherosclerotic progression at sites of low shear stress is attenuated by myeloid-PlexinD1 deficiency through suppression of classical macrophage polarization
|
|
Combined clinical, metabolomic, and polygenic scores for cardiovascular risk prediction
|
|
Sex-specific cardiac ageing and sympathetic compensation: a translational study
|
|
Long forms of cardiac troponin T for myocardial infarction diagnosis: the SuperTROPO study
|
|
Digital profile of children’s hearts: automated echocardiogram strain analysis facilitates earlier detection of cardiac dysfunction
|
|
Diabetes and sudden cardiac death: a Danish nationwide study
|
|
Oestrogen-related receptor γ in sepsis-induced cardiomyopathy: role of cardiomyocyte subtype conversion
|
|
Osimertinib induces reversible cardiac dysfunction through the GATA4-MYLK3-MYL2 axis
|
|
The macrophage-derived motor protein KIF13B enhances MERTK-mediated efferocytosis and prevents atherosclerosis in mice
|
|
Women with chronic coronary artery disease: long-term outcomes after percutaneous coronary intervention vs coronary artery bypass grafting
|
|
Artificial intelligence-enhanced electrocardiography to predict regurgitant valvular heart diseases: an international study
|
|
Temporal trends in the use of oral anticoagulants and clinical outcomes in older, elderly, and very elderly patients with atrial fibrillation: a Danish nationwide study
|
|
Enhanced antigen presentation by macrophages promotes human atherosclerosis progression: therapeutic implications
|
|
Endotypes of angina with non-obstructive coronary arteries: a prospective multicentre study
|
|
High-sensitivity cardiac troponin I and risk of dementia: the 25-year longitudinal Whitehall II study
|
|
Genetic evaluation of early-onset atrial fibrillation: impact on patient management
|
|
Dementia risk across blood pressure categories: a South Korean nationwide study
|
|
Early outcomes of children with univentricular circulation undergoing Fontan surgery: the EuroFontan registry
|
|
Outcomes of moderate mixed aortic valve stenosis and regurgitation
|
|
Atrial cardiomyopathy: markers and outcomes
|
|
Left ventricular geometry, brain architecture, and cognition: an observational study
|
|
Blood pressure, plasma proteins, and cardiovascular diseases: a network Mendelian randomization and observational study
|
|
Antihypertensive treatment in young adults and cardiovascular risk: a population-based cohort study
|
|
Sex differences in atrial fibrillation-related atrial remodelling assessed by electroanatomic mapping and biopsy
|
|
EP4/ANXA2 axis in pulmonary arterial hypertension: therapeutic implications
|
|
Drug-coated vs non-drug-coated devices for femoropopliteal artery interventions: long-term outcomes of the SAFE-PAD study
|
|
Transcriptomic biomarkers related to cardiac disease in childhood cancer survivors: a case-control study
|
|
Left bundle branch area pacing vs right ventricular pacing for atrioventricular block: the MELOS RELOADED study
|
|
Early antiplatelet treatment for minor stroke following thrombolysis: the EAST trial
|
|
Endothelial plasticity in atrial fibrosis by integrating single-cell sequencing and genetic lineage tracing
|
|
Fulminant myocarditis: outcome predictors in an international cohort study
|
|
Cytosolic calcium handling signature: integration with clinical predictors enhances prediction of post-operative atrial fibrillation
|
|
Sex-specific outcomes after transcatheter or surgical treatment of aortic valve stenosis: the DEDICATE-DZHK6 trial
|
|
Surgical left atrial appendage occlusion in valvular heart disease without atrial fibrillation: the OPINION trial
|
|
Temporal modulation of antiplatelet therapy in high-risk patients undergoing complex percutaneous coronary intervention: the TAILORED-CHIP randomized clinical trial
|
|
Arrhythmic genotypes in dilated cardiomyopathy and risk of advanced heart failure
|
|
C-reactive protein and cardiovascular risk among women with no standard modifiable risk factors: evaluating the ‘SMuRF-less but inflamed’
|
|
Surgical myectomy for hypertrophic cardiomyopathy: procedural volume and outcomes
|
|
Atrial fibrillation and atherosclerosis cause different vascular brain lesions on magnetic resonance imaging
|
|
iLIPA/i, a risk locus for coronary artery disease: decoding the variant-to-function relationship
|
|
Coronary function testing vs angiography alone to guide treatment of angina with non-obstructive coronary arteries: the ILIAS ANOCA trial
|
|
Withdrawal of heart failure therapy after atrial fibrillation rhythm control with ejection fraction normalization: the WITHDRAW-AF trial
|
|
Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial
|
|
Titin-related familial dilated cardiomyopathy: factors associated with disease onset
|
|
Low-density lipoprotein cholesterol and cardiovascular risk in the absence of calcifications on computed tomography: the Western Denmark Heart Registry
|
|
Cardiovascular benefit of continuous positive airway pressure according to high-risk obstructive sleep apnoea: a multi-trial analysis
|
|
Heparin administration at first medical contact vs immediately before primary percutaneous coronary intervention: the HELP-PCI trial
|
|
Kidney function trajectories before and after hospitalization for heart failure with reduced ejection fraction
|
|
Excessive glycosylation drives thoracic aortic aneurysm formation through integrated stress response
|
|
Cryoballoon vs radiofrequency ablation in persistent atrial fibrillation: the CRRF-PeAF trial
|
|
Mind the gaps: blood pressure variability and its impact on health
|
|
ApoB and Lp(a): core measures to assess cardiovascular risk
|
|
Colchicine for secondary prevention of vascular events: a meta-analysis of trials
|
|
Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis
|
|
Cumulative exposure to atherogenic lipoprotein particles in young adults and subsequent incident atherosclerotic cardiovascular disease
|
|
Radial vs femoral access for percutaneous coronary intervention: temporal trends and outcomes in the USA
|
|
First myocardial infarction: risk factors, symptoms, and medical therapy
|
|
Long QT syndrome in children and adolescents: risk factors and outcomes in a large German cohort
|
|
Natriuretic targets in acute heart failure with volume overload: are we misguided?
|
|
|
Genes & Development
|
1 |
|
|
|
Genome Research
|
1 |
|
|
|
Hepatology
|
1 |
|
|
|
Human Reproduction
|
1 |
|
|
|
Immunity
|
2 |
|
|
|
International Journal of Epidemiology
|
5 |
|
|
|
International Journal of Obesity
|
15 |
|
|
|
JAMA Internal Medicine
|
9 |
|
|
|
JAMA Pediatrics
|
4 |
|
|
|
JAMA Psychiatry
|
1 |
|
|
|
JAMA Surgery
|
1 |
|
|
|
JAMA: The Journal of the American Medical Association
|
29 |
|
|
|
Journal of Biological Chemistry
|
31 |
|
|
|
Journal of Cleaner Production
|
1 |
|
|
|
Journal of Clinical Endocrinology & Metabolism
|
4 |
|
|
|
Journal of Clinical Investigation
|
31 |
|
|
|
Journal of Clinical Oncology
|
11 |
|
|
|
Journal of Experimental Medicine
|
3 |
|
|
|
Journal of Hepatology
|
1 |
|
|
|
Journal of Infectious Diseases
|
6 |
|
|
|
Journal of Neuroscience
|
1 |
|
|
|
Journal of Physiology
|
50 |
|
|
|
Journal of Thoracic and Cardiovascular Surgery
|
118 |
|
Long-term survival after percutaneous coronary intervention or coronary artery bypass grafting in patients with diabetes and multivessel disease
|
|
Impact and Outcomes of Failure Mode Following Mitral Valve Repair
|
|
Rationale of Functional Tricuspid Annular Dilatation Based on Standardized Intraoperative Measurements
|
|
Trends in Aortic Valve Reintervention: Incidence and Outcomes after Failed TAVI Among Medicare Patients
|
|
Long-Term Outcomes of Postoperative Atrial Fibrillation After Cardiac Surgery: Results from 19,000 Patients
|
|
Left Ventricular Rehabilitation after Ross operation for Critical Aortic Stenosis with Endocardial Fibroelastosis
|
|
Extended Arch Replacement Is Associated with Improved Long-Term Outcomes in Acute Type A Aortic Dissection with Ascending Entry Tear
|
|
Does the Genotype of Hypertrophic Cardiomyopathy Impact the Outcomes of Septal Myectomy?
|
|
Ten-year outcomes of valve-replacing versus valve-sparing aortic root replacement in Marfan syndrome patients: An observational multicenter study
|
|
Simulations Predict Improved Valve Performance Without Direct Leaflet Intervention After Neonatal Truncus Arteriosus Repair
|
|
Randomized trial of tricuspid flexible band versus rigid ring in patients with moderate tricuspid regurgitation or greater: results of the JPH2019 trial
|
|
Outcomes of Adults with Congenital Heart Disease Undergoing Heart and Heart-Liver Transplantation: A Single-Center Experience
|
|
A Prospective, Multicenter Trial of Irrigated Radiofrequency Ablation and Cryoablation to Treat Non-Paroxysmal Atrial Fibrillation
|
|
Ostial Occlusion of All Epicardial Coronary Arteries: Living off Bypass Grafts
|
|
VIRTUAL REALITY IN PLANNING IN COMPLEX HEART SURGERY
|
|
Safety and Efficacy of a Dedicated Pulmonary Thromboendarterectomy Fellowship: the UK Experience at a High-Volume Center
|
|
Morbidity and Mortality Outcomes of Surgical Versus Transcatheter Aortic Valve Replacement in Dialysis-Dependent Patients
|
|
Regurgitant Jet Type Predicts Autograft Outcomes After the Ross Procedure in Congenital Patients
|
|
Cardiac Reoperations in Patients with Prior Thoracic Radiation: A Single-Center Analysis of Outcomes and Key Lessons
|
|
25-Year Outcomes Following the Regionalization of Three Competing Pediatric Cardiac Surgery Programs
|
|
Multi-Center Comparison of Hybrid and Norwood Procedure in Patients with Fontan Circulation
|
|
Mechanical versus bioprosthetic heart valves in patients on hemodialysis
|
|
Clinical Value of the Flow-Adjusted Pressure Gradient in Patients Undergoing Surgical Aortic Valve Replacement
|
|
Outcomes of Staged Repair Following Systemic-to-Pulmonary Artery Shunt in Pulmonary Atresia with Ventricular Septal Defect
|
|
Pathology of Explanted Novel ePTFE Pulmonary Valved Conduits Reveals Paucity of Leaflet Tissue Response but Frequent Non-Adherent Thrombus Formation
|
|
Risk prediction for surgery on adults with congenital heart disease: Nonprocedural clinical and social factors predominate
|
|
Volume–outcome relationship of mortality following surgical explant of transcatheter aortic valve replacements
|
|
Changes in ejection fraction after coronary artery bypass grafting for ischemic cardiomyopathy: Impact on survival and determinants of improvement
|
|
Posterior wall thickness associates with outcomes after septal myectomy in childhood hypertrophic obstructive cardiomyopathy——original article
|
|
Impact of Membranous Septum Length and Valve Calcification on Permanent Pacemaker Implantation After Surgical Aortic Valve Replacement
|
|
Integrin αV emerges as a potential therapeutic target with cautionary implications in thoracic aortic aneurysm and dissection
|
|
Impact of reoperation on very long-term survival in patients with failed mitral valve repair: A 30-year single-center Canadian experience
|
|
Suppression of fibroblastic activity prolongs cardiac transplant survival through targeting their ATG5 expression
|
|
Mid-term outcomes after aortic valve repair with the internal geometric annuloplasty ring
|
|
The influence of reoperation on aortic arch reconstructive surgery: Evidence from a multicenter, national registry
|
|
Sodium-glucose cotransporter 2 inhibitor use and outcomes after surgical aortic valve replacement
|
|
Septal leaflet augmentation during Da Silva cone repair: Valvar function and anatomic features compared to nonpatch repair
|
|
Optimal strategy for aortic root replacement in patients of advanced age: Valve-sparing root replacement or Bio-Bentall?
|
|
Fontan pathway diameter in adults undergoing exercise catheterization: Association with hemodynamics, exercise capacity, and liver scores
|
|
Using preoperative cardiac computed tomographic conduction axis prediction to avoid damage in congenital left ventricular outflow tract and aortic valve surgery
|
|
Comparison of continuous and interrupted sutures in tracheal resection and anastomosis: A cohort study with propensity score matching
|
|
Complications following airway resections: Insights from a large contemporary multi-institutional cohort
|
|
Comparison of myocardial mechanics after mitral valve repair with leaflet preservation versus leaflet resection: A subanalysis of the randomized Canadian Mitral Research Alliance CardioLink-2 trial
|
|
Quality of life after mitral valve surgery: Results from the Cardiothoracic Surgical Trials Network
|
|
Aortic remodeling and pulmonary autograft performance over 2 decades after the Ross procedure in the pediatric and young adult population
|
|
Microinvasive, off-pump, transventricular neochordae implantation in recurrent mitral valve regurgitation after open heart surgical repair
|
|
Diastolic dysfunction persists 3 months after surgical revascularization in a large animal model of hibernating myocardium
|
|
Long-term outcomes of aortic valve repair in children after infancy
|
|
Valve characteristics and surgical options for severe rheumatic mitral stenosis with more than mild regurgitation: A dual-center retrospective study
|
|
Second cross-clamp in less invasive mitral valve repair for degenerative mitral regurgitation: Predictors and outcomes
|
|
Acute type A dissection with iliofemoral or renal malperfusion: Is frozen elephant trunk necessary?
|
|
Contemporary outcomes and health care costs associated with single-ventricle heart failure admissions in adults in the United States
|
|
A novel rat model for group 2 pulmonary hypertension by total pulmonary vein banding: Multi-omics insights into pathophysiological mechanisms
|
|
Mitral valve repair by right minithoracotomy compared with sternotomy: 21-year single-center experience
|
|
Impacts of atrial fibrillation and surgical ablation on rheumatic and degenerative mitral surgeries
|
|
Development of a patient-specific Fontan failure risk calculator using machine learning—a step toward personalized medicine
|
|
Type A aortic dissection during pregnancy and postpartum: Experience in 60 patients over 25 years
|
|
Primary biventricular repair in neonates with borderline left ventricle
|
|
Outcomes of Fontan patients undergoing combined heart-liver transplantation in pediatric hospitals across the United States
|
|
Intraoperative predictors of left atrioventricular valve reoperation after repair of complete atrioventricular septal defect
|
|
Outcomes of ischemic mitral regurgitation after coronary revascularization alone in patients with acute coronary syndrome
|
|
Replacement of the superior vena cava by the bovine pericardium conduit: Sustained patency without long-term anticoagulation
|
|
Comparison of bovine jugular vein conduits and polytetrafluoroethylene valved conduits for right ventricular outflow tract reconstruction
|
|
Worse Survival in Transcatheter Aortic Valve Replacement with Untreated Tricuspid Regurgitation: Implications for Surgical Intervention
|
|
Single Incision Minimally Invasive Congenital Heart Surgery – Insights into Program Development and Outcome
|
|
Tricuspid annular remodeling in tachycardia induced cardiomyopathy with functional tricuspid regurgitation
|
|
Ex Vivo Heart Perfusion Offsets Ischemic Penalties with ≥6-Hour Preservation in Adult Donation-After-Brain-Death Heart Transplantation
|
|
Computational fluid dynamics-based risk stratification of modified Blalock-Taussig-Thomas shunt thrombogenicity
|
|
Long-term outcomes of isolated tricuspid surgery in 3706 patients: Implications for the future
|
|
Iatrogenic aortic dissection: Insights from the International Registry of Acute Aortic Dissection
|
|
A surgeon's toolkit for mitral valve–induced left ventricular outflow tract obstruction with minimal septal hypertrophy
|
|
Early outcomes of chimney commando procedure in redo double valve replacement: A retrospective cohort study
|
|
Totally thoracoscopic transmitral versus transaortic septal myectomy for hypertrophic cardiomyopathy: A propensity score−matched comparative study
|
|
Mitral valve repair versus bioprosthetic replacement outcomes in patients with rheumatic disease over 60: Propensity score–matching results
|
|
Association of increased red blood cell distribution width with adverse cardiorenal outcomes after cardiac surgery
|
|
Long-Term Outcomes for Patients Undergoing Hybrid Ablation for Atrial Fibrillation
|
|
Cardiopulmonary Effects of Vasopressin Versus Norepinephrine in Cardiac Surgery Patients: a Single Cluster-Randomized Cross-over Trial
|
|
Intention-to-treat Outcome Analysis for Valve Sparing Aortic Root Replacement: Is There a Price to Pay for Failure?
|
|
Unplanned reinterventions after congenital cardiac surgery and hospital mortality: A report from the Pediatric Cardiac Critical Care Consortium (PC4)
|
|
Thirty years of left atrioventricular valve reoperations following atrioventricular septal defect repair: Impact of valvar stenosis
|
|
Eliminating the learning curve in robotic mitral valve repair: Results from 1400 patients
|
|
Shifting strategies to address systemic outflow tract obstruction in single ventricle anatomy with transposed great arteries
|
|
Outcomes of thoracoabdominal aortic aneurysm repair in patients with and without peripheral arterial disease
|
|
Reversed septal motion in congenital corrected transposition of the great arteries: A potential mechanism for tricuspid regurgitation
|
|
Pulmonary valve repair at the time of the Ross procedure: a safe and durable strategy to address post-implantation aortic regurgitation
|
|
Metformin’s Effects Beyond Ischemia: Evaluating Cardioprotection in Non-Ischemic Myocardium in a Large Animal Model of Coronary and Metabolic Disease
|
|
Risk of Reoperation Following Rheumatic Mitral Repair: Long-term Longitudinal Analysis
|
|
Long-term Clinical Outcomes of 1020 Open Repairs of Descending Thoracic and Thoracoabdominal Aortic Aneurysms
|
|
Extra-cardiac conduit restriction is associated with increased liver fibrosis in adolescent Fontan patients
|
|
Interpretable Artificial Intelligence to Predict Preoperative Risk Factors for Failure to Rescue after Coronary Artery Bypass Grafting
|
|
Prognostic impacts of biological valve size on long-term outcomes of primary surgical aortic valve replacement for aortic stenosis
|
|
Pediatric heart transplant in donation after circulatory death using normothermic regional perfusion
|
|
Role of primary sternal closure in early outcomes following the Norwood procedure
|
|
Impact of Effective Orifice Area on Long-Term Survival in Bioprosthetic versus Mechanical Aortic Valves
|
|
Nanosecond Pulsed Field Ablation: Feasibility of Creating the Cox-Maze Lesion Set on the Beating Heart
|
|
Platelet Responsiveness to Aspirin in Pediatric Patients Undergoing Cardiac Surgery – A Prospective Cohort Study
|
|
Novel Anastomotic Device for the Sandwich Technique in Type A Aortic Dissections – A Human Cadaver Study
|
|
Autograft Reinforcement in the Ross Procedure: A Systematic Review and Patient-level Meta-Analysis
|
|
Oral anticoagulation in patients with atrial fibrillation and heart valve prosthesis: a substudy from the LAAOS III Trial
|
|
Impact of Preoperative CT Planning on Surgical Outcomes in Patients with Obstructive Hypertrophic Cardiomyopathy: A Prospective Cohort Study
|
|
Effect of Celsior Cold Storage on Warm Ischemia-Induced Myocardial Plasma Membrane Damage and Pyroptosis in Human Hearts from Circulatory Death Donors
|
|
Device closure versus surgical repair for doubly committed subarterial ventricular septal defect
|
|
Survival trends of adults with congenital heart disease after heart surgery in Sweden
|
|
Targeted immunotherapy with sphingosine-1-phosphate improves myocardial contractility and mitochondrial function in a novel murine ex vivo perfusion and transplantation model
|
|
Transcatheter Edge-to-Edge Repair versus Mitral Valve Surgery in Octogenarians: Comparative Analysis of Safety, Durability, and Survival
|
|
Ventricular Arrhythmias in Patients Undergoing Degenerative Mitral Repair: Prevalence and Impact on Survival
|
|
Challenging the Transcatheter-First Paradigm: Redo Surgical Aortic Valve Replacement After Prior Transcatheter or Surgical Aortic Valve Replacement
|
|
Five-Year Experience of Heart Transplantation Following Donation After Circulatory Death
|
|
Symptomatic Myocardial Bridge: Long-term Outcomes and Strategies
|
|
Personalized External Aortic Root Support, the Dutch Experience
|
|
Predictors and Prognosis of Mild Regurgitation After Rheumatic Mitral Valve Repair: A Dual-Center Cohort Analysis Based on Cardiac Computer Tomography
|
|
A cohort evaluation of surgical pathways reported to a national audit of children undergoing treatment for congenital heart disease in England and Wales
|
|
Growth of the Fontan Pathway and its Association with Long-Term Outcomes
|
|
Outcomes Following Repair of Truncus Arteriosus with Interrupted Aortic Arch
|
|
Risk Stratification of CABG Patients Using an Artificial Intelligence ECG-Derived Age
|
|
Early extraction versus conservative management in patients with non-infected cardiac implantable electronic devices undergoing cardiac surgery for left-sided infective endocarditis: Insights from the multicentric CAMPAIGN Registry
|
|
Coronary revascularization in France: six-year trends and outcomes in coronary artery bypass grafting and percutaneous coronary intervention
|
|
Neo-aortic valve regurgitation and root dilation after arterial switch operation in patients with native left ventricular outflow tract obstruction
|
|
|
Journal of the American Academy of Dermatology
|
2 |
|
|
|
Journal of the American Chemical Society
|
4 |
|
|
|
Journal of the American College of Cardiology
|
138 |
|
Contemporary Outcomes of the Ross Procedure in Adults
|
|
Long-Term Outcome of Myectomy Associated With Secondary Mitral Valve Chordal Cutting in Obstructive Hypertrophic Cardiomyopathy
|
|
Population Prevalence of Valvular Heart Disease in the United States
|
|
10-Year Outcomes of SAPIEN 3 Transcatheter Aortic Valve Replacement or Surgery in Intermediate-Risk Patients
|
|
Effects of Finerenone on Sudden Death Across the Cardio-Kidney-Metabolic Landscape A FINE-HEART Analysis
|
|
Estimating the Effects of MTEER in U.S. Practice
|
|
Kidney and Survival Benefits of Semaglutide in Diabetes With Chronic Kidney Disease
|
|
Implications of Modest Reductions in ABI Measurements for Risk of Major Adverse Limb Events Among 223,350 Veterans
|
|
Risk-Based Nurse-Managed Personalized Heart Failure Interventions
|
|
Anti-inflammatory effects of oral NLRP3 inhibition with ruvonoflast among individuals at elevated cardiovascular risk
|
|
Monogenic ALB Variants as Determinants of Severe Hypercholesterolemia A Population-Based Cohort Study
|
|
Effectiveness and Safety of Early Rhythm Control in Patients With Atrial Fibrillation and Chronic Kidney Disease
|
|
ECG Signatures and Long-Term Ischemic Stroke Risk A Deep Learning Analysis of 200,000 Patients
|
|
Long-Term Outcomes of a Drug-Eluting Resorbable Scaffold vs Angioplasty in Infrapopliteal Chronic Limb-Threatening Ischemia 3-Year Results From the LIFE-BTK Trial
|
|
Multiarterial Grafting and Survival After Coronary Artery Bypass Grafting
|
|
Aligning Coronary Stent Trial Enrollment With the U.S. Intended-Use Population
|
|
Sudden Cardiac Death and its Relation to Previously Diagnosed or Occult Cardiac Disease at Autopsy
|
|
Sudden Cardiac Death Due to Myocardial Infarction With Obstructive and Nonobstructive Coronary Arteries
|
|
Randomized Trial of Left Bundle Branch Pacing vs Right Ventricular Pacing in Vulnerable Cardiac Function
|
|
Body Mass Index, Clinical Outcomes, and Mortality in Heart Failure: A Mendelian Randomization Study
|
|
Focal and Diffuse Coronary Artery Disease Patterns and Placebo-Controlled Angina Relief With Percutaneous Coronary Intervention
|
|
Midlife Cardiorespiratory Fitness and Healthy Aging
|
|
Comparative Cardiovascular Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Diabetes Mellitus
|
|
Sirolimus-Eluting Balloon vs Repeat Drug-Eluting Stent or Balloon Angioplasty for Coronary In-Stent Restenosis
|
|
Risk-Guided Atrial Fibrillation Screening With Artificial Intelligence–Enabled Electrocardiogram Models
|
|
Blood Pressure Trajectories and Cardiovascular Outcomes in Older Patients
|
|
Opportunistic Cardiovascular Risk Assessment Using Routine Head CT in the Emergency Department
|
|
Cardiovascular Disease Risk in Adults With Hematological Malignancies
|
|
Quality of Life After Percutaneous Coronary Intervention or Medical Therapy for Chronic Total Coronary Occlusions: EUROCTO and DECISION-CTO Meta-Analysis
|
|
Achieving Intensive Blood Pressure Control in High-Risk Patients: Implementation Insights From the ESPRIT Trial
|
|
Long-Term Cardiovascular and Noncardiovascular Mortality After Acute Coronary Syndrome
|
|
Oral PCSK9 Inhibitor Enlicitide Versus Oral Nonstatin Therapies: A Phase 3 Randomized Clinical Trial
|
|
A Randomized, Placebo-Controlled Trial of Chronic Total Occlusion Percutaneous Coronary Intervention in Stable Angina - ORBITA-CTO
|
|
Automated Alerts to Improve Timely Evaluation and Treatment of Valvular Heart Disease: The ALERT Trial
|
|
Atrial Functional Mitral Regurgitation
|
|
Combining Genomics With Lipid and Inflammatory Biomarkers to Predict Coronary Artery Disease Risk
|
|
Cardiomyopathy Gene Variants and Polygenic Risk Scores in Atrial Fibrillation
|
|
Use of Coronary Artery Calcium Scoring in Individuals With Elevated Lipoprotein(a)
|
|
Comparative Prognosis of Chagas and Other Cardiomyopathies
|
|
Interchangeability of the KCCQ-12 and KCCQ-23 across gt;18,000 Participants Enrolled in 4 Large-Scale Trials of Heart Failure
|
|
Genotype-Guided Risk Stratification of Mitral Valve Surgery in Marfan Syndrome
|
|
Single-Ventricle Disease
|
|
Preferences for Antihypertensive Prescribing in Older Adults
|
|
Use of the Ross Procedure in North America
|
|
Mitral Annular Calcification-Related Mitral Stenosis: 5-Year Outcomes and Prognostic Determinants in the JAMAC Study
|
|
Varenicline and Ventricular Ectopy After Myocardial Infarction: A Randomized Phase 2 Study
|
|
Real-Time Heart Team for Revascularization in Complex Coronary Artery Disease
|
|
Beta-Blocker (Bisoprolol) vs Calcium-Channel Blocker (Verapamil) in Nonobstructive Hypertrophic Cardiomyopathy
|
|
Sotatercept in Pulmonary Arterial Hypertension
|
|
Cardiac Screening for Conditions Associated With Sudden Cardiac Death: Yield, Interventions, and SCA/SCD Incidence in 104,369 Young Individuals
|
|
Mitral Valve Repair for Degenerative MR With Moderate or Less Tricuspid Regurgitation: 2-Year Outcomes From a Multicenter Echocardiographic Core Laboratory–Adjudicated Cohort
|
|
Comparison of Sirolimus- vs Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Artery Disease: The SIRONA Randomized Noninferiority Trial
|
|
Polygenic Risk Based Detection and Treatment of Subclinical Coronary Atherosclerosis in the PROACT Clinical Trials
|
|
Effect of Baduanjin on Blood Pressure Among Individuals With High-Normal Blood Pressure: A Multicenter, Open-Label, Blinded-Outcome Randomized Controlled Trial
|
|
Atrial Mechanical Contraction Predicts Cerebrovascular Risk in Patients With Transthyretin Amyloid Cardiomyopathy and Sinus Rhythm
|
|
Sirolimus-Eluting Iron Bioresorbable Scaffolds vs Everolimus-Eluting Stents for Percutaneous Coronary Intervention: A Randomized Trial (IRONMAN II)
|
|
Pulsed Field Ablation vs Standard Radiofrequency Ablation for Typical Atrial Flutter: ADVANTAGE AF Trial Substudy
|
|
Public Reporting and Case Selection in Congenital Heart Surgery Signals From a Multicenter Observational Study
|
|
Association Between Age and PCI Effectiveness in Stable CAD Secondary Analysis of ORBITA-2
|
|
Enhanced Detection and Prompt Diagnosis of Atrial Fibrillation Using Apple Watch A Randomized Controlled Trial
|
|
Hospitalizations and Mortality Among Medicare Beneficiaries at Cardiovascular Risk Disruptions and Recovery From the COVID-19 Pandemic
|
|
Blood Pressure Levels and Outcomes in Type 2 Diabetes Dose-Response Meta-Analysis of 5.87 Million Cohort Participants
|
|
Natriuretic Peptide Receptor-1 Agonist for Resistant Hypertension A Randomized Phase 2 Trial
|
|
Pulsed-Field Ablation to Enhance the Durability of Pulmonary Vein Isolation and Treat Paroxysmal Atrial Fibrillation
|
|
Heart Failure Quality of Care Among Asian Patients in the United States
|
|
Echocardiographic Diastolic Function Grading in HFpEF Testing the Updated 2025 ASE Criteria
|
|
Loss of Y Chromosome and Major Cardiovascular Events in a Prospective Study of Older Men
|
|
Delayed Diagnosis of Transthyretin Amyloid Cardiomyopathy in the Veterans Health Administration
|
|
Obesity-Associated Cardiovascular Risk and Benefit From PCSK9 Inhibition A Prespecified Analysis From FOURIER
|
|
Prevalence, Awareness, and Treatment of Hypertension in 37 African Countries Trends From 2003 to 2022
|
|
Association of Lp(a) With Cardiovascular Disease and All-Cause Mortality in U.S. Hispanics and Latinos
|
|
Pulsed Field Ablation Using a Novel Biphasic Catheter vs Thermal Ablation for Paroxysmal Atrial Fibrillation InsightPFA Trial
|
|
Early vs Late Staged PCI After Subintimal Tracking and Re-Entry for Chronic Total Occlusions A Randomized Trial
|
|
Trends in Prevalence, Treatment, and Control of Cardiometabolic Risk Factors Among Adults With Hypertension in the United States, 1999-2023
|
|
Trends in the Prevalence, Associated Risk Factors, and Health Burden of Heart Failure in the United States, 1988 to 2023
|
|
Behavioral Economics and Medication Adherence for Hypertension: A Randomized Clinical Trial
|
|
Aficamten in Obstructive Hypertrophic Cardiomyopathy: A Multi-Domain, Patient-Level Analysis of the MAPLE-HCM Trial
|
|
Potent P2Y12 Inhibitor Monotherapy versus DAPT after PCI in Patients With and Without STEMI: NEO-MINDSET Substudy
|
|
One-year outcomes of novel balloon-expandable versus contemporary transcatheter heart valves in severe aortic stenosis: the LANDMARK trial
|
|
Proactive Management and Treatment of Aortic Stenosis: An International Expert Perspective
|
|
Sex-Specific Microaxial Flow Pump Use and Outcomes in Infarct-Related Cardiogenic Shock in the DanGer Shock Trial
|
|
Incremental Value of Cardiac Myosin-Binding Protein C for the Early Diagnosis of Acute Myocardial Infarction
|
|
Follow-up Lipid Testing and Statin Initiation among Young Adults in a US Healthcare System
|
|
Association of Lipoprotein(a) and Interleukin-6 With Cardiovascular Risk MESA and UK Biobank
|
|
Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients: MANIFEST-US
|
|
Using Artificial Intelligence to Adjudicate Major Adverse Cardiovascular Events in Clinical Trials
|
|
Using Transmitral Pressure Gradients and Residual Mitral Regurgitation to Optimize Outcome After Transcatheter Edge-to-Edge Repair
|
|
Safety of Using Risk Stratification Along With High-Sensitivity Cardiac Troponin in the Emergency Department A Secondary Analysis
|
|
Atrial Fibrillation Screening According to Genetic Risk A Secondary Analysis of the Randomized LOOP Study
|
|
Tricuspid Regurgitation Across the Spectrum of Heart Failure With Preserved Ejection Fraction
|
|
Intracoronary Low-Dose Recombinant Tissue Plasminogen Activator in Primary PCI for ST-Segment Elevation Myocardial Infarction and Large Thrombus Burden: A Randomized Trial
|
|
Drug-coated balloon angioplasty versus upfront stenting for de novo CAD: 3-year follow-up of REC-CAGEFREE I trial
|
|
Transcatheter Mitral Valve Replacement for Severe Mitral Annular Calcification: Primary Outcomes from the SUMMIT-MAC Study
|
|
Economic outcomes and quality of life after CABG or PCI for multivessel disease: The FAME 3 Trial
|
|
Long-Term Effect of ICDs in Nonischemic Heart Failure With Reduced Ejection Fraction Extended Follow-Up Analysis of DANISH
|
|
Using PREVENT Equations to Compare Intensive vs Standard Systolic Blood Pressure Control for Primary Prevention in SPRINT
|
|
Modest Effects of Intensive Blood Pressure–Lowering on Quality of Life in Patients at High Cardiovascular Risk The ESPRIT Trial
|
|
Intensive Blood Pressure Control in Older Patients With Hypertension 6-Year Results of the STEP Trial
|
|
Effects of Intensive Blood Pressure Control in Patients With Frailty A Post Hoc Analysis From ESPRIT
|
|
LDL-C related cardiovascular burden in China 2010-2030: Spatiotemporal patterns and scenario-based projections
|
|
Effect of Dapagliflozin on Quality of Life of Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation
|
|
Very High Prevalence of Nonoptimally Controlled Traditional Risk Factors at the Onset of Cardiovascular Disease
|
|
Mechanical Vacuum Aspiration and Debulking of Large Vegetations During Cardiac Implantable Electronic Device Extraction
|
|
Danicamtiv, a selective agonist of cardiac myosin, for dilated cardiomyopathy: A Phase 2 open-label trial
|
|
Association Between Anticoagulant Therapy and Survival in Pulmonary Arterial Hypertension A Registry Report and Updated Meta-Analysis
|
|
Remnant Cholesterol as an Independent Cardiovascular Risk Factor in Young Adults : An Age-Stratified Cohort Study
|
|
Intensive vs Conventional Intraoperative Blood Pressure Management on Cardiovascular Events After Major Abdominal Surgery The BP-CARES Randomized Trial
|
|
Safety and Effectiveness of Statins for Primary Prevention in Adults With Type 1 Diabetes An Emulation
|
|
Trajectories of Angina After Initial Invasive vs Conservative Strategy for Chronic Coronary Disease
|
|
Left Ventricular Health and TAVR Timing in Asymptomatic Severe Aortic Stenosis: Analysis from the EARLY TAVR Trial
|
|
Artificial Intelligence Automation of Echocardiographic Measurements
|
|
Incidence of Heart Failure in Asian American, Native Hawaiian, and Other Pacific Islander Populations
|
|
Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients A Pooled Analysis
|
|
Pathogenic Cardiomyopathy-Associated Gene Variants and Prognosis in Atrial Fibrillation Results in 18,000 Clinical Trial Participants
|
|
Sex Differences in Effectiveness of Semaglutide in Patients with Peripheral Artery Disease: The STRIDE Trial
|
|
Computed Tomography Angiography or Standard Care After Left Main PCI?
|
|
Twice-A-Day CLOpidogrel vs Ticagrelor to Reduce Short-Term MACE after Primary PCI: The TADCLOT Trial
|
|
Personalized or Standard Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: PARTHENOPE Randomized Trial
|
|
Colchicine and Longitudinal Dynamics of Clonal Hematopoiesis: An Exploratory Substudy of the LoDoCo2 Trial
|
|
Effect of Intensive Blood Pressure Control on Stroke A Prespecified Secondary Analysis of the ESPRIT Trial
|
|
A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular Risk
|
|
Natriuretic Peptides, Body Mass Index, and Clinical Outcomes in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
|
|
Effect of Vericiguat on Worsening Heart Failure in Compensated Outpatients with HFrEF: Insights from VICTOR
|
|
Echocardiographic Changes With Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy Exploratory Insights From the ODYSSEY-HCM Trial
|
|
Effect of Aficamten Compared with Metoprolol on Echocardiographic Measures in Symptomatic Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM
|
|
Effects of Mavacamten on Cardiac Biomarkers in Nonobstructive Hypertrophic Cardiomyopathy Insights From the ODYSSEY-HCM Trial
|
|
Anthropometric Measures, Cardiovascular Outcomes, and Treatment Effects of Finerenone in Cardiovascular-Kidney-Metabolic Disease: Pooled Participant-Level Analysis of Three Global Trials
|
|
Causes of Myocardial Infarction in Younger Patients Troponin-Elevation in Persons ≤65 Years Old in Olmsted County
|
|
Prevalence and Predictors of Neurocognitive Dysfunction in Adults With Congenital Heart Disease Results From MINDS-ACHD
|
|
Clinical Outcomes of Conduction System Pacing vs Right Ventricular Septal Pacing in Atrioventricular Block The CSPACE Randomized Controlled Trial
|
|
Paclitaxel-Coated Balloon for the Treatment of Multilayer In-Stent Restenosis AGENT IDE Subgroup Analysis
|
|
Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure With Improved Ejection Fraction
|
|
Sodium-Glucose Cotransporter 2 Inhibitor With and Without an Aldosterone Antagonist for Heart Failure With Preserved Ejection Fraction The SOGALDI-PEF Trial
|
|
Global Impact of Fixed-Dose Combination Therapies on Cardiovascular Mortality and Events, 2023-2050 A Modeling Study
|
|
AHA PREVENT Equations and Cardiovascular Disease Risk in Diverse Health Care Populations
|
|
Plaque Vulnerability and Cardiovascular Risk Factor Burden in Acute Coronary Syndrome An Optical Coherence Tomography Analysis
|
|
Catheter Ablation vs Lifestyle Modification With Antiarrhythmic Drugs to Treat Atrial Fibrillation PRAGUE-25 Trial
|
|
3-Year Clinical Outcomes Comparing the Amulet vs Watchman FLX for Left Atrial Appendage Closure in Patients With Atrial Fibrillation Results From the SWISS-APERO Randomized Clinical Trial
|
|
|
Journal of the American Geriatrics Society
|
9 |
|
|
|
Journal of the American Society of Nephrology
|
5 |
|
|
|
Journal of the National Cancer Institute
|
9 |
|
|
|
Kidney International
|
2 |
|
|
|
Molecular Cell
|
1 |
|
|
|
Molecular Psychiatry
|
1 |
|
|
|
Nano Letters
|
2 |
|
|
|
Nature
|
10 |
|
|
|
Nature Communications
|
161 |
|
Emergence of fibrotic pericytes and their transcriptional regulation in pulmonary fibrosis
|
|
Systemic atopy and upper-airway disease define susceptibility to incident asthma after COVID-19 in Korea
|
|
MYDGF promotes pathological and physiological retinal angiogenesis via the Gαi1/3-Gab1-Akt-mTOR signaling
|
|
Sex representation in trials relative to indication-specific disease burden in FDA-approved drugs (2015–2023)
|
|
Pulmonary inflammation in severe pneumonia is characterised by compartmentalised and mechanistically distinct sub-phenotypes
|
|
Liposomal mitoxantrone plus tislelizumab in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma: a phase 1b/2 trial
|
|
Inhibition of the QPCT–PDIA4 axis rescues ΔF508 and N1303K CFTR in cystic fibrosis
|
|
Single-cell whole-genome sequencing reveals convergent evolution in Burkitt lymphoma
|
|
Optimal blood pressure target in patients with uncomplicated hypertension: a target trial emulation study
|
|
Dynamics of the β-cardiac myosin auto-inhibited state explain cardiomyopathy pathogenesis
|
|
Non-contact on-device detection of obstructive sleep apnea from infrared video
|
|
Compliance modulation of a soft robotic atrioventricular model of heart failure with preserved ejection fraction
|
|
TAK1 drives inflammatory fibroblast acquisition and shapes myocardial infarction responses in male mice
|
|
Measuring multi-site pulse transit time with an AI-enabled mmWave radar
|
|
Metabolic and inflammatory biomarker trajectories after a cancer diagnosis and the risk of cardiovascular diseases
|
|
Mitochondria-derived vesicles with bioenergetic units from brown adipose tissue attenuate cardiac remodeling post-myocardial infarction
|
|
Impact of a whole food, plant-based diet on LDL-cholesterol and cardiovascular risk factors in adults with heterozygous familial hypercholesterolemia: a randomized, two-period, two-treatment, crossover, fully controlled feeding trial
|
|
Endothelial Drp1 integrates VEGF-induced redox signaling with glycolysis through cysteine oxidation to drive angiogenesis
|
|
Joint clinical and molecular subtyping of COPD with variational autoencoders
|
|
Gene-gene interactions between a LMNA variant and common polymorphisms drive early-onset atrial fibrillation
|
|
Kynurenic acid mediates epicardial fat-induced lymphatic metabolic dysfunction in atrial fibrillation
|
|
Maternal age and pregnancy-related cardiovascular complications
|
|
A high dimensionality approach reveals immunopathogenic responses driving severe pediatric acute respiratory distress syndrome
|
|
LTBP4 deficiency inhibits NLRP3 inflammasome activation in cardiomyocytes and attenuates heart failure in male mice
|
|
Cuffless hemodynamic monitoring with physics-informed machine learning models
|
|
Chromatin rewiring of β-globin and MYC enhancers by TGF-β1 drives defective erythropoiesis
|
|
A deep learning ECG model for identification and localization of occlusion myocardial infarction
|
|
Endothelial-erythrocyte glycocalyx exchange enables liquid biopsies of endothelial function
|
|
Persistence of alveolar fibroblast-derived ADAMTS4+ cells in a preclinical model of delayed pulmonary fibrosis resolution
|
|
A self-supervised electrocardiogram foundation model for empowering cardiovascular disease prediction and genetic factor discovery
|
|
Dietary intake and BCAA metabolism regulate pulmonary fibrosis through KDM4A-mediated epigenetic remodeling in male mice
|
|
MicroRNA-30c analog C2 decreases plasma cholesterol and atherosclerosis without causing liver injury in preclinical studies
|
|
Glycaemic variability underlies myocyte dysfunction and myocardial injury risk in diabetes
|
|
International trade and air-quality-related mortality
|
|
Hdac11 promotes idiopathic pulmonary fibrosis through macrophage M2-type polarization and myofibroblast accumulation by inhibiting Parkin-dependent mitophagy
|
|
Precision cardiovascular risk prediction in type 1 diabetes: An IMI2 SOPHIA analysis
|
|
SLC1A5 prevents aortic aneurysm and dissection by glutaminolytic-epigenetic orchestration of vascular smooth muscle cell homeostasis
|
|
Cardiac reprogramming via transient overexpression of P-glycoprotein alleviates doxorubicin-induced cardiotoxicity in mice and pigs
|
|
A synthetic angiotensin II/ACE2-based hormone shunt controlling experimental hypertension
|
|
PDK4 drives abdominal aortic aneurysm by promoting smooth muscle cell metabolic reprogramming and NLRP3-mediated pyroptosis
|
|
Osteoarthritis and analgesic consumption in haemochromatosis HFE C282Y homozygotes with normal or low iron parameters
|
|
Structural insights into single-pass transmembrane receptor GC-A activation by distinct antihypertensive antibodies
|
|
Macrophage Gsα promotes NLRP3 stability and its intervention attenuates abdominal aortic aneurysm in male mice
|
|
Targeting REV-ERBα/BNIP3 axis attenuates pulmonary arterial hypertension by repressing mitophagy in mice
|
|
NK cells promote cardiac cell death and regulate myelopoiesis in myocardial infarction
|
|
Mitochondrial vulnerability underlies myocarditis from COVID-19 mRNA vaccine
|
|
CXCR3 is associated with T-cell-induced heart damage in acute rheumatic fever
|
|
Cardiomyocyte-derived GPX4 stabilizes BNIP3 to facilitate mitophagy and mitigate myocardial ischemia/reperfusion injury
|
|
Zanubrutinib-rituximab followed by shortened chemoimmunotherapy as frontline treatment for mantle cell lymphoma (CHESS): a phase II trial
|
|
Cardiomyocyte Cyclin-dependent kinase 9 directly binds to and phosphorylates NF-κB p65 subunit to drive cardiac inflammation and remodeling
|
|
Single-cell multiomics uncovers an endothelial mechanosensitive PIEZO1-IL-33 axis driving pulmonary fibrosis
|
|
Endothelial C-type natriuretic peptide/guanylyl cyclase-B signaling prevents pulmonary arterial hypertension
|
|
Vascular smooth muscle cell state trajectories mediate molecular mechanisms of coronary disease risk
|
|
Pyruvate metabolism enzyme Dlat induces mitochondria protein hyperacetylation to limit fatty acid oxidation in the HFpEF heart
|
|
The REDD1–NF-κB–miRNAs–eNOS/SIRT1 axis mediates obesity-induced endothelial cell senescence and hypertension
|
|
Optical control of the cardiac rhythm with photoswitchable Na1.5 channel blockers
|
|
Single-cell genomics highlight MYC-associated metabolic activation and altered cell interactions in T-prolymphocytic leukemia progression
|
|
NPM3 functions as a lactyltransferase to promote necroptosis in male diabetic cardiomyopathy mice models via FASN transcription modulation
|
|
Restoration of RBM22 overcomes the transcriptional and epigenetic barriers of cardiomyocyte proliferation for heart regeneration
|
|
Amphotericin B promotes respiratory viral entry by enhancing late endosomal maturation and fusion via glucocerebrosidase-mediated ceramide remodeling
|
|
A gut microbiome-kidney-heart axis predictive of future cardiovascular diseases
|
|
Clusters of vascular aging manifestations predict incident cardiovascular events in the community
|
|
Conditional BCL-2 Expression in Fibroblasts Promotes Persistent Pulmonary Fibrosis which is Reversible by Therapeutic BCL-2 Inhibition
|
|
Activation of IRF3 in cardiomyocytes impairs mitochondrial oxidative function through PGC-1α inhibition and drives heart failure
|
|
TWIST1 drives endothelial-to-mesenchymal-transition to stabilize atherosclerotic plaques
|
|
Depression of tryptophan may contribute to adverse effects of naproxen
|
|
Human iPSC-based Modeling of Pulmonary Fibrosis Reveals p300/CBP Inhibition Suppresses Alveolar Transitional Cell State
|
|
Expert-level probabilistic breathing event detector informs phenotyping of sleep apnea
|
|
The landscape of hereditary haemochromatosis risk and diagnosis across the British Isles and Ireland
|
|
Tenascin C myofibroblasts exacerbate vascular neointimal hyperplasia by propagation of nerve-macrophage interactions in mice
|
|
Endothelial stem cells of the retinal vasculature reside in the optic nerve
|
|
A nanosystem targeting tissue inhibitor of metalloproteinase-1 for continuous spatiotemporal idiopathic pulmonary fibrosis therapy
|
|
CD39 polymorphism enables lung thrombosis in sickle cell disease
|
|
Airway immune profiles and therapeutic implications of IGF1 in eosinophilic granulomatosis with polyangiitis
|
|
Non-remnant triglyceride-rich lipoproteins due to lipoprotein lipase deficiency increase atherosclerosis in mice
|
|
Endoglin as a BMP9 co-receptor in vascular endothelial cells: prodomain displacement and TGFBRII recruitment
|
|
Gut microbiota-derived metabolite isovalerylcarnitine modulates salt sensitivity of blood pressure and incident hypertension: a multicenter dietary salt intervention trial
|
|
Evidence for Interleukin-17C governing interleukin-17A pathogenicity and promoting asthma endotype switching in bronchiectasis
|
|
Calcium channel blockers increase the risk of aortic aneurysm and dissection
|
|
IDH2 lactylation promotes angiogenesis in murine diabetic myocardial infarction via blocking Cav1-eNOS interaction
|
|
Single cell spatial transcriptomics integration deciphers the morphological heterogeneity of atherosclerotic carotid arteries
|
|
GSDME-dependent pyroptosis drives abdominal aortic aneurysm via promoting vascular senescence
|
|
Administrative-driven hierarchical management of atrial fibrillation on cardiovascular events: a prospective matched cohort study
|
|
Molecular insights into ago-allosteric modulation at cysteinyl leukotriene receptor 2
|
|
MAT2A promotes atherosclerotic plaque vulnerability by mediating epigenetic reprogramming of macrophages
|
|
Integrating a host biomarker with a large language model for diagnosis of lower respiratory tract infection
|
|
Nano-functionalized probiotic treats atherosclerosis via inhibiting intestinal microbiota-TMA-TMAO axis
|
|
Liver-specific paraoxonase-1 alleviates regulatory T cell-driven immunosuppression via metabolic reprogramming in hepatocellular carcinoma
|
|
Hic-5 drives epithelial mechanotransduction promoting a feed-forward cycle of bronchoconstriction
|
|
Echo-Vision-FM: a pre-training and fine-tuning framework for echocardiogram video vision foundation model
|
|
Platelet-bioengineered hiPSC-sEVs achieve targeted repair of fibrotic sinoatrial node in preclinical SND models
|
|
A conformal piezoelectric microsystem for demographic-adaptive and calibration-free cuffless blood pressure monitoring
|
|
Modifiable influencing factors and their joint effects on early- and late-onset coronary heart disease
|
|
Comprehensive profiling of smoke-induced T cells in mice implicates clonal γδT17 cells as a hallmark of COPD
|
|
Extracellular activation of HCN4 by a subtype-specific nanobody
|
|
A noninvasive machine learning model using a complete blood count for screening of primary vitreoretinal lymphoma
|
|
Risk factors for mortality in patients with kidney failure on hemodialysis identified by proteomic analysis of CRIC and PACE studies
|
|
Extracellular matrix anchored neutrophils drive pulmonary fibrosis in mice
|
|
NLRP3-induced systemic inflammation controls the development of JAK2V617F mutant myeloproliferative neoplasms
|
|
Identification of epigenetic regulators of fibrotic transformation in cardiac fibroblasts through bulk and single-cell CRISPR screens
|
|
Pharmacogenomics and chronotherapy of drug-induced cardioprotection in acute myocardial infarction
|
|
Regional and cell specific bioactivity of injectable extracellular matrix biomaterials in myocardial infarction
|
|
Deciphering age- and sex-specific patterns of coronary artery atherosclerosis from a large Chinese cohort
|
|
A heterogeneous-structure facial mask for thermal and humidity regulation in cold environments
|
|
CFTR modulator therapy drives microbiome restructuring through improved host physiology in cystic fibrosis: the IMMProveCF phase IV trial
|
|
Crystal structures of Ryanodine Receptor reveal dantrolene and azumolene interactions guiding inhibitor development
|
|
Regulation of lipoprotein processing by GPNMB in foamy macrophages: potential therapeutic targets for atherosclerosis
|
|
Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma
|
|
Genome-wide analysis of heart failure yields insights into disease heterogeneity and enables prognostic prediction in the Japanese population
|
|
A cross-study transcriptional patient map of heart failure defines conserved multicellular coordination in cardiac remodeling
|
|
Multi-cohort high-dimensional proteomics reveals early risk markers for lymphoid cancer subtypes
|
|
Ras-related protein 2 limits vascular smooth muscle cell phenotypic switching and abdominal aortic aneurysm development
|
|
Predicting hypotension, syncope, and fracture risk in patients indicated for antihypertensive treatment: the STRATIFY models
|
|
Eosinophil-derived interleukin-24 compromises epithelial integrity and aggravates airway remodeling in mouse models of allergic asthma
|
|
CCL28 contributes to angiogenesis and cardiac repair through CCR10 endothelial cells after myocardial infarction in male mice
|
|
A wearable-based aging clock associates with disease and behavior
|
|
Chronic kidney disease is associated with increased risk of sudden cardiac death
|
|
The CCL20–integrin α5β1 interaction enhances TGF-β/Smad signaling to promote fibroblast activation in pulmonary fibrosis
|
|
Reprogramming mitochondrial metabolism and epigenetics of macrophages via miR-10a liposomes for atherosclerosis therapy
|
|
Reference values for cardiac dimensions and function in a rural population living in a loiasis-endemic area of the Republic of the Congo: An echocardiographic study
|
|
mTOR dysregulation induces IL-6 and paracrine AT2 cell senescence impeding lung repair in lymphangioleiomyomatosis
|
|
Adipocyte FMO3-derived TMAO induces WAT dysfunction and metabolic disorders by promoting inflammasome activation in ageing
|
|
Hypertrophic cardiomyopathy mutations Y115H and E497D disrupt the folded-back state of human β-cardiac myosin allosterically
|
|
Equitable cleanup of Superfund sites leaving no U.S. community behind
|
|
An anti-TSLP monoclonal antibody for uncontrolled CRSwNP: the DUBHE randomized clinical trial
|
|
Hypoxic conditioning in Parkinson’s disease: randomized controlled multiple N-of-1 trials
|
|
Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma
|
|
Macrophage ferroptosis potentiates GCN2 deficiency induced pulmonary venous arterialization
|
|
Integrated single-cell atlas of human atherosclerotic plaques
|
|
Mepolizumab alters gene regulatory networks of nasal airway type-2 and epithelial inflammation in urban children with asthma
|
|
Lymph nodes molecular subtypes unravel lymph nodes heterogeneity and clinical implications in colorectal cancer
|
|
Transparent artificial intelligence-enabled interpretable and interactive sleep apnea assessment across flexible monitoring scenarios
|
|
Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trial
|
|
Aging affects reprogramming of pulmonary capillary endothelial cells after lung injury in male mice
|
|
A mucosal vaccine prevents eosinophilic allergic airway inflammation by modulating immune responses to allergens in a murine model of airway disease
|
|
Inhibition of epithelial cell YAP-TEAD/LOX signaling attenuates pulmonary fibrosis in preclinical models
|
|
Lung structural cells are altered by infeluenza virus leading to rapid immune protection following re-challenge
|
|
Biomarker panels for improved risk prediction and enhanced biological insights in patients with atrial fibrillation
|
|
Effects of sacubitril/valsartan on hypertensive heart disease: the REVERSE-LVH randomized phase 2 trial
|
|
Integrated multiomics of pressure overload in the human heart prioritizes targets relevant to heart failure
|
|
Spatiotemporal HO flashes coordinate actin cytoskeletal remodeling and regulate cell migration and wound healing
|
|
Tumour initiated purinergic signalling promotes cardiomyocyte RBFOX1 degradation and cardiotoxicity from DNA damaging anticancer agents
|
|
In vivo measurement of an Apelin gradient with a genetically encoded APLNR conformation biosensor
|
|
Cardiomyocyte OTUD1 drives diabetic cardiomyopathy via directly deubiquitinating AMPKα2 and inducing mitochondrial dysfunction
|
|
Scavenger receptor CD163 multimerises to allow uptake of diverse ligands
|
|
Inhibiting CD36 palmitoylation improves cardiac function post-infarction by regulating lipid metabolic homeostasis and autophagy
|
|
Chromatin interaction maps of human arterioles reveal mechanisms for the genetic regulation of blood pressure
|
|
Colchicine in patients with aortic stenosis undergoing transcatheter aortic valve replacement: a double-blind randomized trial
|
|
A programmable platelet theranostic platform for adaptive multi-stage delivery and synergistic immunotherapy in atherosclerosis
|
|
Cross-population GWAS and proteomics improve risk prediction and reveal mechanisms in atrial fibrillation
|
|
Connective tissue disorder and high risk pregnancy: a case series with personalised external aortic root support (PEARS)
|
|
Immature Acta2R179C/+ smooth muscle cells cause moyamoya-like cerebrovascular lesions in mice prevented by boosting OXPHOS
|
|
Imbalanced TGFβ signalling and autophagy drive erythroid priming of hematopoietic stem cells in β-thalassemia
|
|
Mitophagy mitigates mitochondrial fatty acid β-oxidation deficient cardiomyopathy
|
|
Levosimendan for postoperative subclinical heart failure after noncardiac surgery: a randomized, double-blinded, phase III trial
|
|
Multiplexed self-adaptable Janus hydrogels rescue epithelial malfunction to promote complete trachea repair
|
|
Association between self-reported multimorbidity and longitudinal brain Aβ deposition in Alzheimer’s disease
|
|
Stress granule assembly impairs macrophage efferocytosis to aggravate allergic rhinitis in mice
|
|
PI3Kγ signaling controls trafficking of CD8+ T cells between lymphoid and non-lymphoid organs and drives hypertension in a murine model
|
|
Normothermic human kidney preservation drives iron accumulation and ferroptosis
|
|
Phage therapy with nebulized cocktail BX004-A for chronic infections in cystic fibrosis: a randomized first-in-human trial
|
|
|
Nature Genetics
|
2 |
|
|
|
Nature Immunology
|
2 |
|
|
|
Nature Medicine
|
32 |
|
|
|
Nature Sustainability
|
1 |
|
|
|
Ophthalmology
|
2 |
|
|
|
PLOS Genetics
|
7 |
|
|
|
PLOS Medicine
|
10 |
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
|
40 |
|
|
|
Radiology
|
17 |
|
|
|
Science
|
5 |
|
|
|
Science Advances
|
29 |
|
|
|
Science Translational Medicine
|
17 |
|
|
|
Sustainable Cities and Society
|
1 |
|
|
|
The BMJ
|
7 |
|
|
|
The EMBO Journal
|
4 |
|
|
|
The ISME Journal: Multidisciplinary Journal of Microbial Ecology
|
1 |
|
|
|
The Journal of Allergy and Clinical Immunology
|
35 |
|
|
|
The Lancet
|
29 |
|
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study
|
|
Ticagrelor with aspirin dual antiplatelet therapy combined with intravenous thrombolysis in patients with ischaemic stroke in China (TAPIS): a multicentre, double-blind, randomised controlled trial
|
|
Percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main stenosis: 10-year final results from the randomised, open-label, non-inferiority NOBLE trial
|
|
Deferral of percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation (PRO-TAVI): an investigator-initiated, multicentre, open-label, non-inferiority, randomised controlled trial
|
|
Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention: 10-year follow-up of the HOST-EXAM trial
|
|
Angiography-derived fractional flow reserve versus coronary angiography to guide coronary artery bypass grafting in patients undergoing surgical valve procedures with concomitant coronary artery disease in China (FAVOR IV-QVAS): a multicentre, triple-blind, randomised trial
|
|
Prediction of mortality, bleeding, and ischaemic events in patients with cancer and acute coronary syndrome: a model development and validation study
|
|
Abluminus DES+ sirolimus-eluting stent versus everolimus-eluting stent in patients with diabetes and coronary artery disease (ABILITY Diabetes Global): results from a multicentre, randomised controlled trial
|
|
Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial
|
|
Tafasitamab, lenalidomide, and rituximab in relapsed or refractory follicular lymphoma (inMIND): a global, phase 3, randomised controlled trial
|
|
Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): a pivotal, multicentre, single-arm, investigational device exemption study
|
|
Complete versus culprit lesion-only revascularisation for acute myocardial infarction (Complete Revascularisation Trialists' Collaboration): an individual patient data meta-analysis of randomised trials
|
|
Percutaneous transcatheter valve replacement in individuals with mitral regurgitation unsuitable for surgery or transcatheter edge-to-edge repair: a prospective, multicountry, single-arm trial
|
|
Dual antiplatelet therapy after percutaneous coronary intervention according to bleeding risk (HOST-BR): an open-label, multicentre, randomised clinical trial
|
|
Sultiame once per day in obstructive sleep apnoea (FLOW): a multicentre, randomised, double-blind, placebo-controlled, dose-finding, phase 2 trial
|
|
Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2/3 superiority trial
|
|
Budesonide–formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial
|
|
Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery (NEWTON-CABG CardioLink-5): an international, randomised, double-blind, placebo-controlled trial
|
|
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1): a multicentre, participant-masked, registry-based, randomised controlled trial
|
|
Benefit–harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials
|
|
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication (SWEDEPAD 2): a multicentre, participant-masked, registry-based, randomised controlled trial
|
|
Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis
|
|
Immediate versus staged complete revascularisation during index admission in patients with ST-segment elevation myocardial infarction and multivessel disease (OPTION–STEMI): a multicentre, non-inferiority, open-label, randomised trial
|
|
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial
|
|
β blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trials
|
|
Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials
|
|
Blood pressure-lowering efficacy of antihypertensive drugs and their combinations: a systematic review and meta-analysis of randomised, double-blind, placebo-controlled trials
|
|
Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysis
|
|
Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial
|
|
|
The Lancet Diabetes & Endocrinology
|
4 |
|
|
|
The Lancet Global Health
|
3 |
|
|
|
The Lancet Neurology
|
1 |
|
|
|
The Lancet Oncology
|
1 |
|
|
|
The New England Journal of Medicine
|
50 |
|
|
|
Thorax
|
47 |
|
The impact of vitamins A and D on lung function and regulatory epigenetics in adult and childhood asthma
|
|
Performance of multivariable risk prediction algorithms in predicting COPD exacerbations: a population-based study
|
|
Childhood haematological and immunoglobulin trajectories and risk of asthma at 18 years
|
|
Trends in asthma incidence and prevalence in 2 million children and adolescents in Catalonia, Spain, 2010–2024: a population-based cohort study
|
|
Paediatric bronchiectasis phenotypes and their association with clinical outcomes: development and validation in two prospective clinical cohorts
|
|
Survival in congenital central hypoventilation syndrome (CCHS): data from the European CCHS Consortium
|
|
Oxygen-enhanced MRI and multiple breath washout with Short extension reveal cystic fibrosis lung disease progression despite triple modulator therapy
|
|
Circulating CTHRC1 levels are associated with IPF disease severity and survival
|
|
Occupational inhaled exposures and risk of interstitial lung abnormalities in individuals with potential familial susceptibility to pulmonary fibrosis
|
|
Association of blood eosinophils and exhaled nitric oxide with exacerbations in patients with asthma, COPD and asthma+COPD: the NOVELTY study
|
|
At-risk registers integrated into primary care to stop asthma crises in the UK: cluster randomised controlled trial with economic evaluation
|
|
Association between overuse of short-acting β2-agonists and the risk of major adverse cardiovascular events among patients with asthma
|
|
Correlates of 5-year decline in 6-min walk distance in the COPDGene cohort
|
|
Altitude-induced periodic breathing optimises respiratory efficiency during sleep in young healthy males
|
|
Clinical and cost-effectiveness of SPACE for COPD delivered as a pulmonary rehabilitation maintenance programme: a randomised controlled trial
|
|
Atomoxetine plus oxybutynin for obstructive sleep apnoea: a randomised-controlled trial with detailed pathophysiology
|
|
Comparison of Lower Airway Sampling Strategies in Children with Protracted Bacterial Bronchitis (CLASSIC-PBB): a non-randomised, internally controlled, multicentre trial
|
|
Short-term effects of size-fractioned particulate matter on blood pressure in patients with COPD: the key role of inflammatory phenotypes
|
|
Development and validation of the Hypersensitivity Pneumonitis South Asian Questionnaire for Exposure (HP-SAQE): a novel, qualitative and quantitative tool
|
|
Acetazolamide to prevent ventilatory drive withdrawal in REM sleep apnoea: a randomised controlled trial
|
|
Loop gain predicts residual sleep apnoea among people using positive airway pressure
|
|
Transcriptomic signatures of IPF in ALI-cultured airway cells and their therapeutic implications
|
|
Clinical, molecular and microbial characterisation of the eosinophilic endotype of bronchiectasis: data from the EMBARC-BRIDGE study
|
|
Incidence and prevalence of obstructive sleep apnoea and narcolepsy in the UK: a population-based descriptive study
|
|
Extreme value analysis has the potential to improve spirometry interpretation
|
|
Impact of air pollution on lung function in cystic fibrosis over a decade in London: a UK CF Registry study
|
|
Clinical impact of customised positive airway pressure (PAP) therapy interfaces (3DPiPPIn): a single site randomised controlled trial
|
|
Antifibrotic therapy and lung cancer risk in patients with idiopathic pulmonary fibrosis: a large retrospective propensity-weighted cohort study
|
|
Elastic parametric response mapping: quantitative CT scoring for local COPD severity
|
|
Development and validation of PRECISE-X model: predicting first severe exacerbation in COPD
|
|
Disproportionate increase in COPD exacerbation risk for 3 months after discontinuing LAMA or ICS: insights from the FLAME trial
|
|
Heterogeneity of short-term elexacaftor-tezacaftor-ivacaftor response in cystic fibrosis using 129Xe MRI
|
|
Blood eosinophil-guided systemic corticosteroid duration in adults hospitalised for asthma exacerbation: a randomised, controlled, open-label, non-inferiority trial
|
|
Multidisciplinary, non-pharmacological breathlessness intervention service for patients with moderately severe to severe COPD: a randomised controlled trial
|
|
Disproportionate impairment in diffusing capacity predicts pulmonary hypertension with an elevated pulmonary vascular resistance in COPD
|
|
Understanding the bidirectional relationship between chronic respiratory disease and cardiovascular disease using genetic evidence
|
|
Sex differences in outcome after endoscopic lung volume reduction (ELVR) in patients with emphysema: a retrospective analysis of the German Lung Emphysema Registry (LER e.V.)
|
|
Time to diagnosis and long-term outcomes for adults presenting with breathlessness
|
|
Safety, feasibility and efficacy of exercise as an airway clearance technique in cystic fibrosis: a randomised pilot feasibility trial
|
|
Proteomics-based risk prediction and drug targets identification for chronic obstructive pulmonary disease
|
|
Mobile health pulmonary rehabilitation (m-PR): a randomised controlled equivalence trial
|
|
Acute breathlessness as a cause of hospitalisation in Malawi: a prospective, patient-centred study to evaluate causes and outcomes
|
|
Adherence to the EAT-Lancet diet, plasma proteomics and the risk of chronic obstructive pulmonary disease
|
|
Serum IgA isotypes are associated with percent emphysema, wall thickness and lung function decline
|
|
Factors associated with guideline-concordant maintenance inhaled medication for COPD: a population-based, longitudinal cohort study
|
|
Efficacy and safety of novel airway balloon cryoablation system for malignant central airway obstruction: a prospective, multicentre, randomised, non-inferiority study
|
|
Effect of simvastatin on postoperative complications in patients undergoing one-lung ventilation during surgery: the Prevention HARP-2 randomised controlled trial
|
|